Could quantitative liver function tests gain wide acceptance mong hepatologists?

World Journal of Gastroenterology

Volumn 15, Issue 28, 2009, Pages 3457-3461

  Tarantino, Giovanni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Chronic diseases; Fatty liver; Hepatitis; Liver cirrhosis; Liver function tests; Prognosis; Viral

Indexed keywords

4 ACETANISIDINE; CAFFEINE; DEETHYLLIDOCAINE; GALACTOSE; INDOCYANINE GREEN; INTERFERON; PEGINTERFERON; PHENAZONE; RIBAVIRIN; BIOLOGICAL MARKER;

ANTIVIRAL THERAPY; BREATH ANALYSIS; CELL ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; HEPATITIS C; HUMAN; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVING DONOR; LONG TERM CARE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA CLEARANCE; PROGNOSIS; QUANTITATIVE ANALYSIS; GASTROENTEROLOGY; LIVER; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TIME;

BIOLOGICAL MARKERS; CAFFEINE; GASTROENTEROLOGY; HUMANS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; PROGNOSIS; TIME FACTORS;

EID: 70349569062     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.3457     Document Type: Editorial

References (25)

1. Isaacs D, Fitzgerald D. Seven alternatives to evidence-based medicine. Oncologist 2001; 6: 390-391
2. Leevy CM, Mendenhall CL, Lesko W, Howard MM. Estimation of hepatic blood flow with indocyanine green. J Clin Invest 1962; 41: 1169-1179
3. Merkel C, Gatta A, Zoli M, Bolognesi M, Angeli P, Iervese T, Marchesini G, Ruol A. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sci 1991; 36: 1197-1203
4. Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 2005; 12: 16-22
5. Kudo M, Vera DR, Stadalnik RC, Esquivel CO, Trudeau WL, Ikekubo K, Todo A. Measurement of functioning hepatocyte mass via [99mTc]galactosyl-neoglycoalbumin. Dig Dis Sci 1993; 38: 2183-2188
6. Onodera Y, Takahashi K, Togashi T, Sugai Y, Tamaki N, Miyasaka K. Clinical assessment of hepatic functional reserve using 99mTc DTPA galactosyl human serum albumin SPECT to prognosticate chronic hepatic diseases - validation of the use of SPECT and a new indicator. Ann Nucl Med 2003; 17: 181-188
7. Sakka SG. Assessing liver function. Curr Opin Crit Care 2007; 13: 207-214
8. Addario L, Scaglione G, Tritto G, Di Costanzo GG, De Luca M, Lampasi F, Galeota Lanza A, Picciotto FP, Tartaglione MT, Utech W, Macr M, Giannelli E, Ascione A. Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study. Eur J Gastroenterol Hepatol 2006; 18: 713-720
9. Young TH, Tang HS, Lee HS, Hsiong CH, Hu OY. Effects of hyperglycemia on quantitative liver functions by the galactose load test in diabetic rats. Metabolism 2007; 56: 1265-1269
10. Jochum C, Beste M, Penndorf V, Farahani MS, Testa G, Nadalin S, Malago M, Broelsch CE, Gerken G. Quantitative liver function tests in donors and recipients of living donor liver transplantation. Liver Transpl 2006; 12: 544-549
11. Klatt S, Taut C, Mayer D, Adler G, Beckh K. Evaluation of the 13C-methacetin breath test for quantitative liver function testing. Z Gastroenterol 1997; 35: 609-614
12. Braden B, Faust D, Sarrazin U, Zeuzem S, Dietrich CF, Caspary WF, Sarrazin C. 13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther 2005; 21: 179-185
13. Park GJ, Katelaris PH, Jones DB, Seow F, Lin BP, Le Couteur DG, Ngu MC. The C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy. Aliment Pharmacol Ther 2005; 22: 395-403
14. Jover R, Carnicer F, Sanchez-Paya J, Climent E, Sirvent M, Marco JL. Salivary caffeine clearance predicts survival in patients with liver cirrhosis. Am J Gastroenterol 1997; 92: 1905-1908
15. Tarantino G, Conca P, Capone D, Gentile A, Polichetti G, Basile V. Reliability of total overnight salivary caffeine assessment (TOSCA) for liver function evaluation in compensated cirrhotic patients. Eur J Clin Pharmacol 2006; 62: 605-612
16. Ryeom HK, Kim SH, Kim JY, Kim HJ, Lee JM, Chang YM, Kim YS, Kang DS. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA. Korean J Radiol 2004; 5: 231-239
17. Ocker M, Ganslmayer M, Zopf S, Gahr S, Janson C, Hahn EG, Herold C. Improvement of quantitative testing of liver function in patients with chronic hepatitis C after installment of antiviral therapy. World J Gastroenterol 2005; 11: 5521-5524
18. Grofte T, Wolthers T, Jensen SA, Moller N, Jorgensen JO, Tygstrup N, Orskov H, Vilstrup H. Effects of growth hormone and insulin-like growth factor-I singly and in combination on in vivo capacity of urea synthesis, gene expression of urea cycle enzymes, and organ nitrogen contents in rats. Hepatology 1997; 25: 964-969
19. Gravholt CH, Poulsen HE, Ott P, Christiansen JS, Vilstrup H. Quantitative liver functions in Turner syndrome with and without hormone replacement therapy. Eur J Endocrinol 2007; 156: 679-686
20. Schmilovitz-Weiss H, Niv Y, Pappo O, Halpern M, Sulkes J, Braun M, Barak N, Rotman Y, Cohen M, Waked A, Tur-Kaspa R, Ben-Ari Z. The 13C-caffeine breath test detects significant fibrosis in patients with nonalcoholic steatohepatitis. J Clin Gastroenterol 2008; 42: 408-412
21. Portincasa P, Grattagliano I, Lauterburg BH, Palmieri VO, Palasciano G, Stellaard F. Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clin Sci (Lond) 2006; 111: 135-143
22. Wasserman K, Zhang YY, Gitt A, Belardinelli R, Koike A, Lubarsky L, Agostoni PG. Lung function and exercise gas exchange in chronic heart failure. Circulation 1997; 96: 2221-2227
23. Elias J Jr, Altun E, Zacks S, Armao DM, Woosley JT, Semelka RC. MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging. Magn Reson Imaging 2009; Apr 6. [Epub ahead of print]
24. Duman DG, Dede F, Akin H, Sen F, Turoglu HT, Celikel C, Tozun N. Colloid scintigraphy in non-alcoholic steatohepatitis: a conventional diagnostic method for an emerging disease. Nucl Med Commun 2006; 27: 387-393
25. Lalazar G, Adar T, Ilan Y. Point-of-care continuous (13)C-methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial. World J Gastroenterol 2009; 15: 966-972